POLISCOPE
Back to bills

The civic record

Read. Follow. Verify.

Massachusetts Bill H.1241 permits health plans to reimburse medical cannabis certifications and cover medical cannabis

Original title: An Act relative to fair access for qualifying patients

Last action · March 12, 2026: Accompanied a study order, see H5226Sponsor: David LeBoeuf

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Would Do

Massachusetts Bill H.1241 authorizes health care providers certifying patients under medical use laws to receive reimbursement from qualifying health plans and allows health plans to include medical cannabis in their formularies if classified under specific drug schedules.

Why it matters

Patients seeking medical cannabis certification and coverage could see changes in out-of-pocket costs and insurance participation depending on whether health plans choose to cover medical cannabis and reimburse certifying providers.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

health care providers

Providers certifying patients under Chapter 94I may become eligible for reimbursement for such certifications from regulated health plans.

Directly affected

qualifying health plans

Regulated health plans are permitted to include medical cannabis in their formularies and may face reimbursement obligations for provider certifications.

Key Facts

You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.

Frequently Asked Questions

Can health plans in Massachusetts cover medical cannabis under this bill?
Yes, health plans may include medical cannabis for medical use in their , provided it is listed on Schedule II, III, IV, V, or VI of the .
Are health care providers guaranteed reimbursement for patient certifications?
The bill states that providers certifying a patient in accordance with Chapter 94I may be eligible for reimbursement by qualifying health plans.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

4 actions
  1. Mar 12, 2026House
    Accompanied a study order, see H5226
  2. Oct 2, 2025Joint
    Hearing scheduled for 10/14/2025 from 10:30 AM-01:00 PM in A-1
  3. Feb 27, 2025Senate
    Senate concurred
  4. Feb 27, 2025HouseCommittee
    Referred to the committee on Financial Services

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

cross reference90% confidence

Accompanied a Study Order

The bill was accompanied by a study order (H5226) according to legislative progress records.

Connected Entities

Drug Control Program, David LeBoeuf, Department of Public Health
OrganizationDrug Control Program“Maintains drug schedules relevant to medical cannabis inclusion”Map →
PersonDavid LeBoeuf“Representative who filed the petition for House, No. 1241”Map →
OrganizationDepartment of Public Health“Houses the Drug Control Program determining drug schedules”Map →

Sources

Open source document

malegislature.gov

Analysis Score

0–100
  • Significance60
    How much this matters to a regular citizen
  • Controversy50
    Intensity of disagreement among stakeholders
  • Entertainment5
    Compellingness for a non-policy-wonk reader
  • Buzz25
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record